Musclepharm (MSLP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MSLP Annual Balance Sheets →
This balance sheet overview for Musclepharm spans from Mar 31 2021 to Mar 31 2022, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2022)
(Dec 31 2021) (Sep 30 2021) (Jun 30 2021) (Mar 31 2021)
Assets
Cash & cash equivalent0.53
Cash & Short-term Investments0.00
Accounts receivable9.28
Inventories0.98
Prepaid Expense And Other Assets Current1.05
Total Current Assets11.84
Equipment/Property/Plant Net0.00
Intangible Assets0.00
Other Assets, Noncurrent0.14
Total Assets11.98
Liabilities
Accounts Payable, Current AC18.88
Accrued Liabilities And Other Liabilities6.65
Short-term Debt7.74
Other Liabilities, Current14.90
Total Current Liabilities48.17
Other Long-term Debt, Noncurrent OT1.86
Total Long-term Debt1.86
Other liabilities, Noncurrent0.00
Accounts Payables And Accrued Liabilities0.23
Total Liabilities50.03
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock183.79
Retained Earnings / Accumulated Deficit-211.84
Other Equity-10.04
Common Stockholder's Equity-38.06
Total Stockholder's Equity-38.06
Liabilities & Stockholder's Equity11.98
4 historic quarters locked

Sign in to unlock the full Musclepharm balance sheet history.

About Musclepharm Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-22-013900

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.